Thanks. The only consideration regarding warrants post their exercise is how many shares will eventual earnings have to be spread across. I have every confidence in the world that there will be substantial earnings to be achieved no matter the number of eventual shares outstanding.
I remain long, patient and waiting for the news that will make both the hiring of John Norris and the retention of The Dilenschneider Group all make perfect sense. Right now, I have my guesses...and I think I'm on target; still, confirmation from the company should soon be made known.
Until then, just watching. On a T/A basis, we are still churning through the digestion process and while I wish we wouln't have fallen this far, the overall market took a bit of a tumble (until yesterday), biotechs have also corrected as a group and the MMs needed a good shake to make some money (generate trading activity) and I think they've just about wrapped that aspect of this correction up.
We may have to work through some overhead supply on the way up and that may slow progress a bit....unless we get "the news" that many of us are expecting. If so, it's quite possible that we'll blow right througfh any remaining overhead supply, take out the old high at $.43 and challenge an even higher level. I have no doubt we'll get there...just offering a few of my thoughts on how we may get there.
GLTA.
Renman
AI
Market Data 
Markets 
